Clinical trial
Development and Validation of a New Prognostic System for Patients With Hepatocellular Carcinoma: A Cohort Study in China
NCT06550739 is registered in ClinicalTrials.gov with Haike Lei as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Development and Validation of a New Prognostic System for Patients With Hepatocellular Carcinoma: A Cohort Study in China
- Lead sponsor
- Haike Lei
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2019
- Completion date
- April 30, 2024
- Enrollment
- 1,053 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hepatocellular carcinoma